Myopia Control: A Case Study on the Best Techniques with Ortho-K

Are we doing enough to ensure effective myopia control in children?

As parents and professionals, we share a common concern: the rising prevalence of myopia and its long-term consequences. Managing myopia progression is not just about improving vision today—it’s about protecting eye health for the future.

In this article, we’ll explore a real-world case of a 10-year-old patient who underwent advanced myopia control treatment in our clinic. Combining the Ji-Yu method with customised Ortho-k lenses and cutting-edge tools like Myopia Master, we achieved remarkable results.

Discover how precise axial length tracking and evidence-based care can make a measurable difference in myopia management.

Case Study: Advanced Myopia Control in a 10-Year-Old Patient

Effective myopia control demands precision and a personalised approach. In our clinic, we treated a 10-year-old boy of Chinese heritage whose baseline measurements highlighted the need for advanced intervention:
???? Axial Length: 25.13 mm (RE), 25.01 mm (LE)
???? Refraction: RE -2.50 -1.75 x 179°, LE -2.50 -1.75 x 177°

To manage his condition, we applied the Ji-Yu method, a tailored strategy integrating:

  • Wave Contact Lenses software: Used to design Ortho-k lenses with Form Free geometry for superior fit and effectiveness.
  • Acuity 200 material: Ensures maximum oxygen permeability to protect corneal health over extended wear periods.
  • Myopia Master by Oculus: Sequential biometry to monitor axial length progression accurately and provide clear, actionable data.
Especialista en Queratocono

After two years of treatment, the outcomes were remarkable:
???? Axial Length Stability: 25.15 mm (RE), 25.02 mm (LE)
????️ Visual Acuity: 20/20 in both eyes

These results showcase how combining tailored lens designs with precise biometric tracking can stabilise myopia progression effectively, even in challenging cases.

Why the Ji-Yu Method Works

The Ji-Yu method integrates advanced technology with a patient-centred focus, making it ideal for children at risk of rapid myopia progression:

  1. Custom Ortho-k Designs: By leveraging tools like Wave Contact Lenses software, we ensure a perfect fit, enhanced comfort, and optimal treatment results.
  2. Axial Length Tracking with Myopia Master: Provides continuous monitoring, allowing us to validate the efficacy of the treatment in real time.
  3. Evidence-Based Results: Our data-driven approach reassures families, offering a tangible “litmus test” to measure success.

Research and Clinical Excellence

Our commitment to innovation extends beyond the clinic. At EVER 2024, we presented our findings on combining low-level red light therapy with Ortho-k for myopia control. This combination of therapies has shown promising results in further stabilising axial elongation in young patients (read more here).

With the Ji-Yu method, we demonstrate that personalised care, powered by advanced technology, is the future of myopia control.

Conclusions: The Future of Myopia Control

The success of this case highlights the transformative potential of integrating advanced technology with customised treatment methods. Myopia control is not a one-size-fits-all approach—it requires precise tools, expert knowledge, and a commitment to evidence-based care.

The Ji-Yu method, supported by sequential biometry using Myopia Master and custom Ortho-k designs, offers:

  • Proven Stability: Axial length tracking demonstrates measurable success over time.
  • Reassurance for Families: Data-driven results build trust and confidence in the treatment.
  • Comprehensive Care: Combining tools like Wave Contact Lenses software and Acuity 200 material ensures both effectiveness and safety.

This approach not only provides superior outcomes for patients but also sets a new standard in clinical excellence. As demonstrated in our EVER 2024 research, combining innovative methods like low-level red light therapy with Ortho-k holds even greater promise for the future of myopia management.

Let’s lead the way toward a better vision for our patients, one case at a time.